TransCode Therapeutics, Inc.

TickerRNAZ

Sector · IndustryHealthcareBiotechnology

SecurityCommon Stock · UQ

CUSIP89357L105

Watch

Share

Ask AIAsk AI about RNAZ

5

Holders

$81,822

Total Value

25% (4)

Consensus

1 buying - 3 selling

Fund holdings as of Jun 30, 2026

RNAZ institutional ownership changes in Q2 2026: 1 institution opened or added positions, 3 trimmed or exited. RNAZ (TransCode Therapeutics, Inc.) is held by 5 institutional investors as of Q2 2026. Top institutional shareholders: Vanguard Capital Management LLC ($40,644), Vanguard Fiduciary Trust Co. ($18,518), UBS Group AG ($17,934). Institutions were selling, on balance.

Smart Money Verdict

View all

Loading verdict

Institutional (13F)••

Insider (Form 4)••

Activist (13D/13G)••

Congressional (STOCK Act)••

Holder Quality

••

★★★★★

Elite

••

★★★★

Strong

••

★★★

Solid

••

★★

Below

••

★

Weak

Held by 5 funds

Who's Trading

Latest move

Source dates: Price Nov 6, 2026 · Insiders Aug 5, 2026 · Activists none · Congress none

InsiderInsDEDEFJ, LLCEntityC 11.8M shAug 3, 2026

InsiderInsDEDEFJ, LLCEntityC 2.0M shAug 3, 2026

View all insider trades

Top Holders

FundsInsidersCongressActivists

Holdings (5)History

AllNewIncreasedHeldDecreasedExitedFirst report

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
VAVanguard Capital Management LLC	Unchanged	6,545	$40,644	0.0%	-82.69%	0
VFVanguard Fiduciary Trust Co.	Unchanged	2,982	$18,518	0.0%	-82.69%	0
UBS Group AG	Decreased	2,888(-65.2%)	$17,934	0.0%	-81.31%	0
FMR LLC	New	706	$4,384	0.0%	-76.01%	22
Wells Fargo & Company	Unchanged	55	$342	0.0%	-82.69%	0
Royal Bank of Canada	Exited	0(-100.0%)	$0	0.0%	—	0
Geode Capital Management, LLC	Exited	0(-100.0%)	$109,690	0.0%	-27.87%	0

Latest insider trades

Insider	Trade	Traded
DEFJ, LLC	C 11.8M sh	Aug 3, 2026
DEFJ, LLC	C 2.0M sh	Aug 3, 2026

Loading Congress trades…

Loading activist filings…

RNAZTransCode Therapeutics, Inc.

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

UNHUnitedHealth Group Incorporated

417 holders · $300.5B

LLYEli Lilly and Company

416 holders · $881.6B

TMOThermo Fisher Scientific Inc

401 holders · $151.5B

JNJJohnson & Johnson

398 holders · $415.6B

DHRDanaher Corporation

395 holders · $98.9B

ISRGIntuitive Surgical, Inc.

394 holders · $111.8B

MRKMerck & Company, Inc.

391 holders · $230.3B

ABBVAbbVie Inc.

386 holders · $303.9B

BSXBoston Scientific Corporation

386 holders · $52.4B

ABTAbbott Laboratories

383 holders · $114.2B

Questions investors ask about RNAZ

Who owns RNAZ?

5 institutional investors held RNAZ on June 30, 2026, led by Vanguard Capital Management LLC ($40,644), Vanguard Fiduciary Trust Co. ($18,518) and UBS Group AG ($17,934).

How many hedge funds hold RNAZ?

5 institutional investors reported RNAZ in their 13F filings for the quarter ended June 30, 2026, $81,822 in all.

Are institutions buying or selling RNAZ?

Selling, on balance. In Q2 2026, 3 institutions trimmed or exited RNAZ and 1 institution opened or added to a position.

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer